Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 8Thoracic 6Gastrointestinal 6Other hematologic neoplasm 4Classical hematology 4Gynecologic 3Genitourinary 2Breast 2Sarcoma 1Plasma cell 1NET 1Myeloid 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 9481Triple Negative Breast Neoplasms 635Neoplasms 413Lung Neoplasms 342Prostatic Neoplasms 321Ovarian Neoplasms 299Colorectal Neoplasms 289Neoplasm Metastasis 280Motor Activity 267Carcinoma, Intraductal, Noninfiltrating 231Colonic Neoplasms 193Breast Neoplasms, Male 172Lymphedema 170Melanoma 158Pancreatic Neoplasms 152Breast Carcinoma In Situ 151Carcinoma, Non-Small-Cell Lung 149Uterine Cervical Neoplasms 144Fatigue 140Head and Neck Neoplasms 132Pain 122Breast Cancer Female 122Brain Neoplasms 118Stomach Neoplasms 117Sarcoma 106Depression 105Breast Cancer Lymphedema 101Anxiety Disorders 101Lymphoma 96Cardiotoxicity 89

Interventions

Vaccines 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lymphadenopathy × Breast × Clear all
NCT04872738 2026-01-06

LymphVAX

Massachusetts General Hospital

Completed
714 enrolled 7 charts
Breast

Lymphadenopathy, Breast Cancer Lymphedema, COVID-19, Breast Neoplasms

NCT06429020 2024-05-24

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Chimei Medical Center

Completed
1,089 enrolled
Breast

Lymphadenopathy, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡